Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Roche Holding Ltd.
Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics

Roche Holding AG operates as a research healthcare company.

It operates through the following segments: Diagnostics and Pharmaceuticals.

The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.

The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process.

The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Number of employees : 93 734 persons.
Sales per Businesses
20162017Delta
CHF (in Million)%CHF (in Million)%
Pharmaceuticals41,04781.2%43,50481.6% +5.99%
Diagnostics11,58922.9%12,24223% +5.63%
Sales per Regions
20162017Delta
CHF (in Million)%CHF (in Million)%
United States22,95945.4%24,97546.9% +8.78%
Rest of Europe10,26720.3%10,15219% -1.12%
Rest of Asia6,47112.8%6,83812.8% +5.67%
Japan4,2438.4%4,2678% +0.57%
Germany3,0326%3,0705.8% +1.25%
Latin America2,6815.3%3,0245.7% +12.79%
Africa, Australia and Oceania1,3352.6%1,4682.8% +9.96%
Rest of North America852.001.7%898.001.7% +5.4%
Switzerland796.001.6%1,0542% +32.41%
Managers
NameAgeSinceTitle
Severin Schwan512008Chief Executive Officer & Executive Director
Christoph Franz582011Chairman
Alan Hippe, PhD672011Chief Financial & Information Technology Officer
John Irving Bell, MD662001Non-Executive Director
Andreas Oeri, MD691996Independent Non-Executive Director
Paul Bulcke642011Non-Executive Director
Peter R. Voser592011Non-Executive Director
André S. Hoffmann, MBA591996Vice Chairman
Bernard J. Poussot662015Non-Executive Director
Richard P. Lifton MD, PhD652015Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 702,562,700 693,849,723 98.8% 8,712,977 1.2% 83.5%
Share B 1 160,000,000 26,557,237 16.6% 0 0.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 18,267,335 2.60%
Norges Bank Investment Management 17,458,196 2.48%
UBS AG (Investment Management) 12,257,151 1.74%
Roche Holding AG 9,200,000 1.31%
BlackRock Fund Advisors 8,797,862 1.25%
PRIMECAP Management Co. 7,637,193 1.09%
Fidelity Management & Research Co. 6,935,873 0.99%
Credit Suisse Asset Management (Schweiz) AG 6,224,049 0.89%
Wellington Management Co. LLP 6,181,218 0.88%
Dodge & Cox 6,037,930 0.86%
Holdings
NameEquities%Valuation
Chugai Pharmaceutical Co Ltd (4519) 335,223,00059.9%16,958,153,853 USD
Roche Holding Ltd. (ROG) 9,200,0001.31%2,104,970,856 USD
Foundation Medicine Inc (FMI) 21,019,11157.0%1,655,254,991 USD
Senseonics Holdings Inc (SENS) 28,345,27620.7%85,035,828 USD
Curetis (CURE) 966,4896.22%6,608,823 USD
Company contact information
Roche Holding AG
Grenzacherstrasse 124
Basel, Basel-Stadt (Basle Town) 4070

Phone : +41.61.688.11.11
Fax : +41.61.691.93.91
Web : www.roche.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.-12.15%193 887
JOHNSON & JOHNSON-6.57%342 627
PFIZER0.30%217 064
NOVARTIS-4.37%213 465
MERCK AND COMPANY4.71%158 813
AMGEN0.56%117 021
ABBOTT LABORATORIES4.78%103 942
BAYER-3.56%102 645
SANOFI-8.41%102 299
GLAXOSMITHKLINE7.49%100 124
NOVO NORDISK A/S-12.38%95 622
ASTRAZENECA-3.06%89 830
ELI LILLY AND COMPANY-5.38%87 110
BRISTOL-MYERS SQUIBB COMPANY-14.52%85 512
CELGENE CORPORATION-12.71%68 456
ALLERGAN PLC1.99%57 246
SHIRE-3.74%48 903
TAKEDA PHARMACEUTICAL CO LTD-21.62%37 708
JIANGSU HENGRUI MEDICINE CO LTD17.24%37 093
SAMSUNG BIOLOGICS CO LTD--.--%33 630
ASTELLAS PHARMA INC9.79%30 425
Connections : Roche Holding Ltd.
Givaudan Foundation
International Federation of Pharmaceutical Manufacturers
European Round Table of Industrialists
International Committee of the Red Cross
International Business Leaders Advisory Council
Fondation Dr Henri Dubois-Ferrière Dinu Lipatti
Fondation pour l’art musical, lyrique et chorégraphique
Credit Suisse (Schweiz) AG
Credit Suisse AG
Weidenfeld Hoffmann Trust
Swiss-American Chamber of Commerce
New York Genome Center
Roche Holdings, Inc.
Zurich Insurance Co. Ltd.
Temasek Holdings (Pte) Ltd.
Stadler Rail AG
Fondation Hoffmann
Fondation Internationale du Banc d'Arguin
WWF International
Inovalon, Inc.
Zurich Insurance Group Ltd.
Lucerne Festival
Fondation Tour du Valat
Voith GmbH
Fondation Auxiliaire du Conservatoire botanique de la Ville de
Immunocore Ltd.
Fondation Jan Michalski Pour L'écriture Et La Littérature
The Oxford Health Alliance
The Rockefeller University
GMEC Management Co. Ltd.
Office for Strategic Co-ordination of Health Research
St. Gallen Foundation for International Studies
Oxford Sciences Innovation Plc
Oxagen Ltd.
Catalyst, Inc.
Oxford University Hospitals NHS Trust
Peter G. Peterson Institute for International Economics
The Gray Laboratory Cancer Research Trust
Fondation MAVA
Rhodes Trust
Fondation Pro Valat
The Ewelme Almshouse Charity
Institute For Strategic Dialogue
Genomics England Ltd.
Oxford Centre for Diabetes Endocrinology & Metabolism
Amazentis SA
The Jenner Institute Laboratories
Glyndebourne Productions Ltd.
Fondation les Corbillettes
Cereal Partners Worldwide SA
Peace Parks Foundation
2030 Water Resources Group
Paul Sacher Stiftung
Tate Gallery Foundation, Inc.
Fondation Prince Albert II of Monaco
Eisenhower Fellowships, Inc.
Systemiq Ltd.
Fort Dodge Animal Health, Inc.
University of Oxford
Nestlé Health Science SA
Max Planck Florida Institute for Neuroscience
Nestlé Skin Health SA
Cargill, Inc.
L'Oréal USA, Inc.
ESCP Europe Campus Paris
Forum Mondial de L'Economie
The Rockefeller Archive Center
IMD Scholarship Foundation
Yale School of Medicine
© 2018 People , Fundamentals and Ownership